Mechanometabolic regulation of CAR-NK cells in solid tumors: evidence, engineering hypotheses, and translational constraints

CAR-NK cells offer an allogeneic and potentially safer platform for adoptive cell therapy, yet their activity in solid tumors remains inconsistent and often limited by poor trafficking, short persistence, antigen heterogeneity, and suppressive tumor microenvironments. This narrative Review examines an underintegrated dimension of CAR-NK failure: the interaction between metabolic stress and mechanical constraints within solid tumors. We integrate evidence from NK/CAR-NK studies, related T-cell systems, and tumor mechanobiology across three axes: mitochondrial adaptation to hypoxia, lipid handling under nutrient stress, and responses to mechanically restrictive tumor environments. Hypoxia-associated mitochondrial fragmentation has mechanistic support in NK cells, with emerging evidence that DRP1 disruption preserves CAR-NK cytotoxicity under hypoxia. Lipid-associated NK-cell dysfunction is supported across several disease contexts, whereas CPT1A overexpression, SOAT1 inhibition, and GPX4/FSP1 augmentation remain candidate CAR-NK strategies. PIEZO1-dependent NK-cell mechanosensing is experimentally supported, but its proposed coupling to YAP/TAZ-mediated metabolic dysfunction requires direct validation. We propose that future CAR-NK design should combine antigen recognition with context-restricted metabolic and mechanobiological support, including inducible circuits, cytokine armoring, checkpoint editing, and standardized iPSC-derived and donor-derived allogeneic platforms. We distinguish interventions supported by direct preclinical CAR-NK evidence from candidate designs requiring validation, and identify the functional, safety, and manufacturing requirements for further translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-12
DOI
https://doi.org/10.3389/fimmu.2026.1947080
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mechanometabolic regulation of CAR-NK cells in solid tumors: evidence, engineering hypotheses, and translational constraints

Miao Cheng, ShiBiao Liu, Mingru Jiang, Zhanhao Liang et al.
Frontiers in Immunology
Immune Cell Function and Interaction
article

Mechanometabolic regulation of CAR-NK cells in solid tumors: evidence, engineering hypotheses, and translational constraints

Miao Cheng, ShiBiao Liu, Mingru Jiang, Zhanhao Liang, Meizhu Zhou, Yiming Wang, Xutong Zhao, Wei Zhang, Yi Zhao, Chaofu Li
article en

Abstract

CAR-NK cells offer an allogeneic and potentially safer platform for adoptive cell therapy, yet their activity in solid tumors remains inconsistent and often limited by poor trafficking, short persistence, antigen heterogeneity, and suppressive tumor microenvironments. This narrative Review examines an underintegrated dimension of CAR-NK failure: the interaction between metabolic stress and mechanical constraints within solid tumors. We integrate evidence from NK/CAR-NK studies, related T-cell systems, and tumor mechanobiology across three axes: mitochondrial adaptation to hypoxia, lipid handling under nutrient stress, and responses to mechanically restrictive tumor environments. Hypoxia-associated mitochondrial fragmentation has mechanistic support in NK cells, with emerging evidence that DRP1 disruption preserves CAR-NK cytotoxicity under hypoxia. Lipid-associated NK-cell dysfunction is supported across several disease contexts, whereas CPT1A overexpression, SOAT1 inhibition, and GPX4/FSP1 augmentation remain candidate CAR-NK strategies. PIEZO1-dependent NK-cell mechanosensing is experimentally supported, but its proposed coupling to YAP/TAZ-mediated metabolic dysfunction requires direct validation. We propose that future CAR-NK design should combine antigen recognition with context-restricted metabolic and mechanobiological support, including inducible circuits, cytokine armoring, checkpoint editing, and standardized iPSC-derived and donor-derived allogeneic platforms. We distinguish interventions supported by direct preclinical CAR-NK evidence from candidate designs requiring validation, and identify the functional, safety, and manufacturing requirements for further translation.

Frontiers in ImmunologyVol. 17
Hubei University of Medicine (CN), Dalian Medical University (CN), Fourth Affiliated Hospital of Guangxi Medical University (CN), First Affiliated Hospital of Dalian Medical University (CN), Beijing Tsinghua Chang Gung Hospital (CN), Tsinghua University (CN)
Good health and well-being
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon